来自异形性肺纤维化患者的肺部居民介质干细胞中的线粒体功能障碍
Josep Mercader-Barceló1,2, Aina Martín-Medina1, Joan Truyols-Vives2
1iRESPIRE Research Group, Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
Cells
|August 26, 2023
概括
线粒体功能障碍在异常性肺纤维化 (IPF) 中损害了肺内存介质干细胞 (LRMSC). 这种细胞缺陷限制了LRMSC功能,可能导致IPF的发展和进展.
科学领域:
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
- 线粒体生物学 线粒体生物学
背景情况:
- 异常性肺纤维化 (IPF) 涉及异常的细胞外矩阵修复.
- 肺部寄居介质干细胞 (LRMSC) 有关,但它们在IPF中的作用尚不清楚.
研究的目的:
- 调查LRMSC在IPF中的作用和功能.
- 分析IPF患者LRMSC的转录和功能差异.
主要方法:
- 来自IPF和对照患者的LRMSC的转录组分析.
- 功能性测试评估线粒体呼吸和自.
- 基因组丰富和过度代表性分析.
主要成果:
- IPF LRMSC 呈现出失调的氧化酸化和线粒体呼吸功能受损.
- 在IPFLRMSC中,线粒体功能障碍与自身食功能受损和减少亲细胞亡基因表达有关.
- 在IPF LRMSC中,TGFβ加剧了线粒体功能障碍.
结论:
- 线粒体功能障碍是IPFLRMSC的一个关键事件.
- 由于线粒体缺陷导致的LRMSC功能受损可能会导致IPF的发病.
相关概念视频
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Alveoli and Alveolar Ducts
The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...


